Akero Therapeutics IncNASDAQ:AKRO
- LAST PRICE45.3900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots40.0000/ 2
- Ask / Lots45.9900/ 2
- Open / Previous Close0.0000 / 45.3900
- Day Range---
- 52 Week Range
- Volume35
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AKRO |
|---|---|---|
| 09:32 ET | 2016 | 47.175 |
| 09:33 ET | 729 | 46.45 |
| 09:35 ET | 353 | 45.93 |
| 09:37 ET | 200 | 46.0825 |
| 09:39 ET | 3900 | 46.01 |
| 09:42 ET | 400 | 46.17 |
| 09:44 ET | 400 | 46.36 |
| 09:46 ET | 700 | 46.16 |
| 09:50 ET | 1200 | 46.3 |
| 09:51 ET | 400 | 46.365 |
| 09:53 ET | 1400 | 46.04 |
| 09:55 ET | 1500 | 46.06 |
| 09:57 ET | 499 | 46.2 |
| 10:00 ET | 300 | 46.12 |
| 10:02 ET | 600 | 46.19 |
| 10:04 ET | 400 | 46.05 |
| 10:06 ET | 400 | 46.1 |
| 10:08 ET | 600 | 46.23 |
| 10:09 ET | 1500 | 46.2602 |
| 10:11 ET | 212 | 46.39 |
| 10:13 ET | 600 | 46.28 |
| 10:15 ET | 300 | 46.39 |
| 10:18 ET | 114 | 46.39 |
| 10:20 ET | 262 | 46.41 |
| 10:22 ET | 200 | 46.35 |
| 10:24 ET | 899 | 46.07 |
| 10:26 ET | 700 | 46.085 |
| 10:27 ET | 300 | 46.02 |
| 10:29 ET | 400 | 46.02 |
| 10:31 ET | 2721 | 46.14 |
| 10:33 ET | 3400 | 46.12 |
| 10:36 ET | 1200 | 46.05 |
| 10:38 ET | 400 | 46.02 |
| 10:44 ET | 100 | 46.22 |
| 10:45 ET | 594 | 46.08 |
| 10:49 ET | 100 | 46.08 |
| 10:56 ET | 100 | 46.01 |
| 11:00 ET | 400 | 46.14 |
| 11:02 ET | 800 | 46.22 |
| 11:03 ET | 400 | 46.02 |
| 11:05 ET | 300 | 46.05 |
| 11:07 ET | 103 | 46.015 |
| 11:09 ET | 500 | 46.12 |
| 11:12 ET | 300 | 46.02 |
| 11:14 ET | 4815 | 45.81 |
| 11:20 ET | 1150 | 45.679 |
| 11:21 ET | 367 | 45.76 |
| 11:23 ET | 1387 | 45.57 |
| 11:25 ET | 100 | 45.59 |
| 11:27 ET | 300 | 45.62 |
| 11:30 ET | 500 | 45.585 |
| 11:32 ET | 300 | 45.62 |
| 11:34 ET | 100 | 45.79 |
| 11:41 ET | 700 | 45.85 |
| 11:50 ET | 1117 | 45.8 |
| 11:52 ET | 500 | 45.875 |
| 11:54 ET | 1705 | 45.85 |
| 11:56 ET | 3793 | 45.7175 |
| 11:57 ET | 17200 | 45.695 |
| 11:59 ET | 600 | 45.705 |
| 12:01 ET | 300 | 45.8 |
| 12:03 ET | 200 | 45.92 |
| 12:08 ET | 600 | 45.63 |
| 12:10 ET | 500 | 45.77 |
| 12:12 ET | 2500 | 45.73 |
| 12:15 ET | 300 | 45.79 |
| 12:17 ET | 8225 | 45.4 |
| 12:19 ET | 4939 | 45.535 |
| 12:21 ET | 600 | 45.275 |
| 12:24 ET | 896 | 45.26 |
| 12:26 ET | 902 | 45.4 |
| 12:28 ET | 3041 | 45.2 |
| 12:30 ET | 1815 | 45.1787 |
| 12:32 ET | 1696 | 45.3 |
| 12:33 ET | 200 | 45.26 |
| 12:35 ET | 100 | 45.29 |
| 12:37 ET | 699 | 45.215 |
| 12:39 ET | 100 | 45.275 |
| 12:42 ET | 1300 | 45.355 |
| 12:44 ET | 700 | 45.35 |
| 12:46 ET | 600 | 45.5 |
| 12:48 ET | 1700 | 45.42 |
| 12:50 ET | 1681 | 45.51 |
| 12:51 ET | 1190 | 45.38 |
| 12:53 ET | 800 | 45.4 |
| 12:55 ET | 400 | 45.4 |
| 12:57 ET | 1158 | 45.5 |
| 01:00 ET | 1902 | 45.32 |
| 01:02 ET | 391 | 45.255 |
| 01:04 ET | 139 | 45.2 |
| 01:06 ET | 3040 | 45.3 |
| 01:08 ET | 550 | 45.29 |
| 01:09 ET | 1179 | 45.2401 |
| 01:11 ET | 600 | 45.23 |
| 01:13 ET | 2600 | 45.43 |
| 01:15 ET | 3031 | 45.19 |
| 01:18 ET | 1444 | 45.21 |
| 01:20 ET | 300 | 45.34 |
| 01:22 ET | 1100 | 45.21 |
| 01:24 ET | 500 | 45.22 |
| 01:27 ET | 200 | 45.32 |
| 01:29 ET | 1530 | 45.02 |
| 01:31 ET | 400 | 45.12 |
| 01:33 ET | 3218 | 45.09 |
| 01:36 ET | 6567 | 44.97 |
| 01:38 ET | 2731 | 45.05 |
| 01:42 ET | 1329 | 45.04 |
| 01:44 ET | 871 | 44.965 |
| 01:45 ET | 1990 | 45.005 |
| 01:47 ET | 100 | 44.95 |
| 01:49 ET | 100 | 44.94 |
| 01:51 ET | 200 | 44.95 |
| 01:54 ET | 2398 | 45.1 |
| 01:56 ET | 300 | 45.17 |
| 01:58 ET | 1070 | 45.065 |
| 02:00 ET | 1050 | 45.07 |
| 02:02 ET | 1100 | 45.15 |
| 02:03 ET | 256 | 45.03 |
| 02:05 ET | 800 | 45.1 |
| 02:07 ET | 2532 | 45.13 |
| 02:09 ET | 600 | 45.065 |
| 02:14 ET | 100 | 45.07 |
| 02:16 ET | 3290 | 45 |
| 02:18 ET | 1300 | 45.13 |
| 02:20 ET | 860 | 44.99 |
| 02:21 ET | 900 | 45.1 |
| 02:23 ET | 1100 | 45.035 |
| 02:25 ET | 2090 | 45.12 |
| 02:27 ET | 1100 | 45.0146 |
| 02:30 ET | 1201 | 45.06 |
| 02:32 ET | 793 | 45.05 |
| 02:34 ET | 1220 | 45.23 |
| 02:36 ET | 1252 | 45.11 |
| 02:39 ET | 1909 | 45.15 |
| 02:41 ET | 1000 | 45.11 |
| 02:43 ET | 1100 | 45.06 |
| 02:45 ET | 700 | 45.01 |
| 02:48 ET | 500 | 45.085 |
| 02:50 ET | 6086 | 45 |
| 02:52 ET | 300 | 44.98 |
| 02:54 ET | 600 | 44.97 |
| 02:56 ET | 300 | 45.1 |
| 02:57 ET | 200 | 45.06 |
| 02:59 ET | 2200 | 45.1 |
| 03:01 ET | 1111 | 45.09 |
| 03:03 ET | 700 | 45.04 |
| 03:06 ET | 6880 | 44.93 |
| 03:08 ET | 200 | 44.935 |
| 03:10 ET | 679 | 44.89 |
| 03:12 ET | 300 | 45.01 |
| 03:15 ET | 1100 | 45.09 |
| 03:17 ET | 225 | 45.05 |
| 03:19 ET | 700 | 45.115 |
| 03:21 ET | 1075 | 45.07 |
| 03:24 ET | 400 | 45.12 |
| 03:26 ET | 1196 | 45.07 |
| 03:28 ET | 600 | 45.055 |
| 03:30 ET | 1110 | 45.12 |
| 03:32 ET | 536 | 45.15 |
| 03:33 ET | 885 | 45.12 |
| 03:35 ET | 3315 | 45.015 |
| 03:37 ET | 1117 | 45.11 |
| 03:39 ET | 2104 | 45.16 |
| 03:42 ET | 1920 | 45.2 |
| 03:44 ET | 761 | 45.255 |
| 03:46 ET | 1399 | 45.48 |
| 03:48 ET | 2600 | 45.46 |
| 03:50 ET | 2400 | 45.45 |
| 03:51 ET | 3470 | 45.54 |
| 03:53 ET | 6950 | 45.52 |
| 03:55 ET | 8952 | 45.68 |
| 03:57 ET | 5531 | 45.535 |
| 04:00 ET | 127432 | 45.39 |
Feb 3, 2023
Insider Sell: Akero Therapeutics, from 5:33PM ET on Friday Feb 03, 2023 by MT Newswires
5:33PM ET on Friday Feb 03, 2023 by MT Newswires
Jan 27, 2023
Morgan Stanley Upgrades Akero Therapeutics to Overweight From Equal Weight, $65 Price Target, from 9:41AM ET on Friday Jan 27, 2023 by MT Newswires
9:41AM ET on Friday Jan 27, 2023 by MT Newswires
Jan 18, 2023
Insider Sell: Akero Therapeutics, from 5:35PM ET on Wednesday Jan 18, 2023 by MT Newswires
5:35PM ET on Wednesday Jan 18, 2023 by MT Newswires
Jan 10, 2023
Akero Therapeutics Appoints Patrick Lamy as Senior Vice President, Commercial Strategy, from 8:00AM ET on Tuesday Jan 10, 2023 by GlobeNewswire
8:00AM ET on Tuesday Jan 10, 2023 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Akero Therapeutics Inc | 2.1B | -13.5x | --- |
Krystal Biotech Inc | 2.1B | -15.5x | --- |
Celldex Therapeutics Inc | 2.2B | -20.3x | --- |
Prime Medicine Inc | 2.0B | -11.3x | --- |
SpringWorks Therapeutics Inc | 2.0B | -6.0x | --- |
Amylyx Pharmaceuticals Inc | 2.4B | -10.8x | --- |
Company Information
Akero Therapeutics Inc. is a clinical-stage company that develops transformational treatments for patients with serious metabolic diseases. The Company is engaged to treat non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Its lead product candidate, efruxifermin (EFX), is an analog of fibroblast growth factor 21 (FGF21), which is a hormone that protects against cellular stress and regulates the metabolism of lipids, carbohydrates and proteins throughout the body. EFX is being evaluated in two Phase IIb clinical trials in patients with biopsy-confirmed NASH: the study in pre-cirrhotic patients with F2-F3 fibrosis and the SYMMETRY study in cirrhotic patients with compensated F4 fibrosis. Its EFX program is focused on patients with cirrhotic NASH (F4, compensated) in Phase IIb clinical trial.
Contact Information
- Headquarters
- 601 Gateway Boulevard, Suite 350SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 650-487-6488
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Mark Iwicki
- President, Chief Executive Officer, Director
- Andrew Cheng
- Co-Founder, Chief Operating Officer, Executive Vice President, Secretary
- Jonathan Young
- Co-Founder, Chief Scientific Officer
- Timothy Rolph
- Chief Financial Officer, Executive Vice President and Head of Corporate Development and Treasurer
- William White
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.1B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 46.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.96 |
EPS | $-3.37 |
Book Value | $4.85 |
P/E Ratio | -13.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
